MetaCap

NexGel (NXGL) vs Vivos Therapeutics (VVOS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Vivos Therapeutics is the larger company by market cap ($5.0 million vs $97,622), about 51.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NXGL-15.35%VVOS-0.99%
+1%-8%-16%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NXGL versus VVOS key metrics
MetricNXGLVVOS
Share price$0.2003$0.1489
Market cap$97.62K$5.00M
1-day change+33.53%-0.40%
EPS (TTM)$-14.80$-1.88
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$57.00$3.28
52-week low$0.151$0.129
Distance from 52-week high-99.65%-95.46%
Analyst consensusholdnone
Avg. price target upside—+1323.77%
Average volume37.86K12.57M
Shares outstanding487.38K33.61M
Employees19268
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Vivos Therapeutics is about 51.3 times larger than NexGel by market value ($5.00M vs $97.62K).

About NexGel

NXGL stock →

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.

Health Care · Medical/Dental Instruments · 19 employees

About Vivos Therapeutics

VVOS stock →

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Health Care · Medical/Dental Instruments · 268 employees

NXGL vs VVOS FAQ

Which is bigger, NexGel or Vivos Therapeutics?

Vivos Therapeutics (VVOS) is larger, with a market capitalization of $5.00M compared with $97.62K for NexGel (NXGL).

Are NexGel and Vivos Therapeutics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons